Setmelanotide: First Approval

2021/02/01 by Anthony Markham · 29 citations
Neuroscience · Medicine · #Regulation of Appetite and Obesity #Diet and metabolism studies #Pancreatic function and diabetes

paper · doi:10.1007/s40265-021-01470-9

Cited by

• Excess body weight: Novel insights into its roles in obesity comorbidities
• Biallelic pathogenic variants in POMC can cause combined pituitary hormonal deficiency associated with severe obesity
• An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
• Improvement of Analysis and Transferability in Peptide Purification: From HPLC to FPLC and Back Again
• Obesity, POMC, and POMC-processing Enzymes: Surprising Results From Animal Models. [europepmc]
• Recent Advances and Perspectives on Expanding the Chemical Diversity of Lasso Peptides. [europepmc]
• Treatment of Acquired Hypothalamic Obesity: Now and the Future. [europepmc]
• Natural History of Obesity Due to POMC, PCSK1, and LEPR Deficiency and the Impact of Setmelanotide. [europepmc]
• Effects of Heterozygous Variants in the Leptin-Melanocortin Pathway on Roux-en-Y Gastric Bypass Outcomes: a 15-Year Case-Control Study. [europepmc]
• The Impact Once-Weekly Semaglutide 2.4 mg Will Have on Clinical Practice: A Focus on the STEP Trials. [europepmc]
• Early onset obesity due to a mutation in the human leptin receptor gene. [europepmc]
• Signaling pathways in obesity: mechanisms and therapeutic interventions. [europepmc]
• Childhood Obesity: Position Statement of Polish Society of Pediatrics, Polish Society for Pediatric Obesity, Polish Society of Pediatric Endocrinology and Diabetes, the College of Family Physicians in Poland and Polish Association for Study on Obesity. [europepmc]
• Genetics of Obesity in Humans: A Clinical Review. [europepmc]
• Ligands for Melanocortin Receptors: Beyond Melanocyte-Stimulating Hormones and Adrenocorticotropin. [europepmc]
• The Role of the Gut Microbiome in Pediatric Obesity and Bariatric Surgery. [europepmc]
• The unique structural characteristics of the Kir 7.1 inward rectifier potassium channel: a novel player in energy homeostasis control. [europepmc]
• Pharmacological Support for the Treatment of Obesity-Present and Future. [europepmc]
• Clinical Trials in Prader-Willi Syndrome: A Review. [europepmc]
• Neurotransmitters in Type 2 Diabetes and the Control of Systemic and Central Energy Balance. [europepmc]
• The treatment of obesity in children and adolescents: consensus position statement of the Italian society of pediatric endocrinology and diabetology, Italian Society of Pediatrics and Italian Society of Pediatric Surgery. [europepmc]
• Breaking down silos: the multifaceted nature of obesity and the future of weight management. [europepmc]
• Adipose Tissue Hyperplasia and Hypertrophy in Common and Syndromic Obesity-The Case of BBS Obesity. [europepmc]
• Prevalence of genetic causes of obesity in clinical practice. [europepmc]
• Adenylate cyclase 3: a potential genetic link between obesity and major depressive disorder. [europepmc]
• The melanocortin-4 receptor pathway and the emergence of precision medicine in obesity management. [europepmc]
• Comparison of Protocols to Test Peptide Stability in Blood Plasma and Cell Culture Supernatants. [europepmc]
• Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: An Obesity Medicine Association (OMA) and expert joint perspective 2025. [europepmc]
• Obesity: pathophysiology and therapeutic interventions. [europepmc]